There's a new sheriff in town in Silicon Valley: the FDA
Regulators raising questions about startups' products, suspecting they're promising more than they can deliver
Tue, May 03, 2016 - 5:50 AM
Founder and CEO Helmy Eltoukhy (left, with chief technology officer AmirAli Talasaz) says Guardant Health is a leading contender among firms working on "liquid biopsy" tests for cancers.
HELMY Eltoukhy's company is on a roll. The startup is a leading contender in the crowded field of firms working on "liquid biopsy" tests that aim to be able to tell in a single blood draw whether a person has cancer.
Venture investors are backing Guardant Health to...